John E. Pandolfino, MD, ’97, ’01 GME, ’05 MSCI, New Gastroenterology Chief Developing Overarching Digestive Disease Center
Browsing: Clinical Breakthroughs
Published in PLOS ONE, the findings by a group of neurosurgeons could change the manner in which a fairly common lumbar procedure is performed in the future.
Taking one pill instead of three could be a powerful ally to prevent cardiovascular disease.
Depressive symptoms increased over the first five years of fatherhood for young men who were around 25 years old when they became fathers and lived in the same home as their children.
Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
Developed by Gregory Dumanian, MD, and Todd A Kuiken, MD, PhD, targeted muscle reinnervation enables an amputee to control motorized prosthetic devices and regain sensory feedback. New research also shows that it reduces neuroma pain from cut nerve endings.
The effort has already combined more than a million patient records in the Windy City and recently received a $7 million grant from the Patient-Centered Outcomes Research Institute.
A newly funded study will be used to identify brain and behavioral indicators at preschool age that predict whether or not early onset mental health problems persist through adolescence.
An intravaginal ring, developed by Northwestern scientist Patrick Kiser, is the first device to be tested in women with the potential to protect against HIV, herpes and unwanted pregnancy.
David Liss, PhD, found that more comprehensive primary care reduced specialist referrals in patients with treated hypertension, helping to ensure that specialists are seeing the patients who would benefit most from their expertise.